Views: 0 Author: Site Editor Publish Time: 2026-03-20 Origin: Site
India’s pharma exports are pushing past $50 billion in 2026. That’s a serious number. It changes how buyers see Indian equipment.
Chamunda isn’t a “cheap alternative” anymore. That framing is outdated. It’s become a real contender on the performance-to-price ratio.
Chamunda’s Giga Press and Élan series both use a dual-turret structure.
The engineering logic is clear.
Pre/main compression balance: roughly 10 tons each. That helps with high-viscosity powders at speed.
Capping becomes less of a fight.
Filling depth range: some models like the SRTM go up to 30 mm fill depth.
That matters for OTC and large supplement tablets.
In 2026, smart buyers model equipment value before signing anything.
A simple ROI framework looks like this:
ROI = ( (P_hourly × H_year × (1 − R_waste)) − C_maintenance ) / P_initial
P_hourly: hourly output. Élan is often cited around 1,000,000 tablets/hour.
That’s a big numerator.
R_waste: reject rate. Chamunda’s typical range is around 5% for standard runs.
Local spare parts help keep C_maintenance lower than European counterparts.
| Dimension | Chamunda (Élan / Giga) | Hanyoo (HY-Series) | European (Korsch / Fette) |
|---|---|---|---|
| Peak output | Very high (~1M tablets/h) | Mid-high (600k–800k/h) | Very high (1M+/h) |
| Smart monitoring | Basic SCADA | AI-driven real-time monitoring | Full Industry 4.0 |
| Certifications | cGMP, partial FDA | CE, ISO, FDA full coverage | Top-tier compliance |
| OEM flexibility | High (strong local customization) | Very high (modular interface) | Low (highly standardized) |
| Price range | $45k–$70k | $35k–$60k | $120k+ |
Chamunda is built for raw output. That’s its identity. But two gaps often come up in real buying conversations.
Gap 1: International compliance documentation.
If your tablets ship to Europe or North America, full CE and FDA paperwork matters.
Hanyoo frames a complete compliance document package as a selling point.
Gap 2: Predictive quality control.
Traditional hydraulic protection reacts after a problem starts.
Hanyoo’s pitch is millisecond-level powder humidity detection with auto-adjustment.
The claimed waste rate target is ~2.5% vs the Chamunda baseline of ~5%.
Gap 3: Fast OEM changeover.
Two-week turnaround on modular tooling is the framing here.
It’s aimed at high-mix, low-volume factories that switch products frequently.
Simple read: if your plant is India-based and you want maximum output, Chamunda makes sense. If you’re targeting global markets with compliance and AI-assisted quality control, Hanyoo offers a different ROI story.
Validate stated output: ask for a continuous 24-hour run log at 100 RPM.
Marketing throughput and sustained real throughput are often different numbers.
Test pressure consistency at FAT: watch the standard deviation of compression force.
That’s where quality differences show up fastest.
Lock in spare parts logistics: confirm a 48-hour response parts center near your production site.
Downtime is always the hidden cost nobody budgets for.
Q: How stable is Chamunda’s multi-layer tablet press?
A: Multi-layer models support three-layer production. Cited output is around 71,000 tablets/hour for that configuration.
It’s slower than single-layer. But physical API separation is the real value, not speed.
Q: What’s the tariff risk on Chamunda equipment in 2026?
A: RCEP and bilateral trade agreements are gradually reducing tariffs on Indian pharma machinery.
But always verify the OEM country of origin. Anti-dumping rules can still surprise buyers.
